PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 6 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Disease Genital Warts 1,791 540 0.01 -0.84 0.30 0.59
Cancer 1,053,491 Disease Disease Arthralgia Syndrome 23 7 0.00 -0.83 0.30 0.56
Cancer 1,053,491 Disease Drug Aldara (Imiquimod)- FDA 36 11 0.00 -0.83 0.31 0.56
Cancer 1,053,491 Disease Target Epiregulin 291 91 0.01 -0.83 0.31 0.58
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
Cancer 1,053,491 Disease Drug Doxorubicin Analogue 25 8 0.00 -0.82 0.32 0.56
Cancer 1,053,491 Disease Target AKT2 873 284 0.01 -0.82 0.33 0.59
Cancer 1,053,491 Disease Target CHK1 2,044 681 0.01 -0.82 0.33 0.60
Cancer 1,053,491 Disease Target Equilibrative Nucleoside Transporter 1 211 71 0.00 -0.81 0.34 0.58
Cancer 1,053,491 Disease Target BRSK1 20 7 0.00 -0.81 0.35 0.56
Cancer 1,053,491 Disease Drug Doxorubicin Hydrochloride 581 204 0.01 -0.81 0.35 0.59
Cancer 1,053,491 Disease Drug Aredia (Pamidronate Disodium)- FDA 14 5 0.00 -0.80 0.36 0.56
Cancer 1,053,491 Disease Target Multidrug Resistance Protein 1 495 183 0.01 -0.79 0.37 0.59
Cancer 1,053,491 Disease Target Aurora A kinase 318 118 0.01 -0.79 0.37 0.58
Cancer 1,053,491 Disease Drug Dromostanolone 8 3 0.00 -0.79 0.38 0.56
Cancer 1,053,491 Disease Disease Carcinoma Head 24 9 0.00 -0.79 0.38 0.57
Cancer 1,053,491 Disease Disease Fibrocystic Breast Disease 173 65 0.00 -0.79 0.38 0.58
Cancer 1,053,491 Disease Target CHK2 1,391 533 0.01 -0.79 0.38 0.60
Cancer 1,053,491 Disease Target Insulin-Like Growth Factor 1 Receptor 1,052 405 0.01 -0.78 0.38 0.59
Cancer 1,053,491 Disease Disease Neutropenia 25,934 9,960 0.06 -0.78 0.38 0.64
Cancer 1,053,491 Disease Disease Carcinoma Prostate 68 27 0.00 -0.78 0.40 0.57
Cancer 1,053,491 Disease Target AKT3 293 117 0.01 -0.77 0.40 0.58
Cancer 1,053,491 Disease Drug Aloxi (Palonosetron hydrochloride)- FDA 10 4 0.00 -0.77 0.40 0.56
Cancer 1,053,491 Disease Drug Doxorubicin 28,033 11,365 0.07 -0.77 0.41 0.64
Cancer 1,053,491 Disease Target ERBB3 1,154 481 0.01 -0.76 0.42 0.60
Cancer 1,053,491 Disease Disease Carcinoma Squamous Cell 47 20 0.00 -0.76 0.43 0.57
Cancer 1,053,491 Disease Disease Lung Carcinoma 13,423 5,796 0.05 -0.75 0.43 0.63
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Cancer 1,053,491 Disease Target EPHA2 532 239 0.01 -0.74 0.45 0.59
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Cancer 1,053,491 Disease Disease Familial Adenomatous Polyposis 3,742 1,737 0.03 -0.73 0.46 0.61
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Drug Adriamycin PFS (Doxorubicin hydrochloride)- FDA 1 1 0.00 -0.71 1.00 0.57
Cancer 1,053,491 Disease Drug Actiq (Fentanyl Citrate)- FDA 1 1 0.00 -0.71 1.00 0.57
Cancer 1,053,491 Disease Drug Abeohyousterone 1 1 0.00 -0.71 1.00 0.57
Cancer 1,053,491 Disease Disease Sever Condition 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Alli (Orlistat 60 mg)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Dragonamide E 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Drimenin 4 2 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Drug Aflibercept (Eylea)- FDA 14 7 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Drug Amifostine (Ethyol)- FDA 14 7 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Target Aurora Kinase A 196 103 0.01 -0.69 0.53 0.59
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59